Screening for High-risk Chronic Obstructive Pulmonary Disease
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: questionnaire survey.
- Кому может быть актуально
- Состояния в реестре: High-risk COPD. Базовые параметры: 18 лет — 80 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Китай
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Screening Study at High-risk Chronic Obstructive Pulmonary Disease
Обзор
This study is a multicenter cross-sectional study design aimed at screening risk factors for the combination of disease and syndrome in high-risk individuals with chronic obstructive pulmonary disease (COPD).
Подробное описание
Targeting high-risk populations for chronic obstructive pulmonary disease (COPD), targeted at key issues such as unclear risk factors and lack of prevention and treatment plans, high-risk population screening was conducted to identify risk factors. This study is expected to detect at least 3600 high-risk individuals with early-stage chronic obstructive pulmonary disease. The incidence rate of high-risk individuals in the early stage of chronic obstructive pulmonary disease is 30%, which means the total screening population is 12000 cases.
Вмешательства
- Другое questionnaire survey
subjects fill out questionnaires
Первичные конечные точки
- COPD screening questionnaire from Terrassa (EGARPOC) [Срок оценки: During screening]
- COPD assessment in primary care to identify undiagnosed respiratory disease and exacerbation risk questionnaire (CAPTURE) [Срок оценки: During screening]
- COPD Assessment Test (CAT) [Срок оценки: During screening]
- COPD screening questionnaire (COPD-Q) [Срок оценки: During screening]
- chronic obstructive pulmonary disease diagnostic questionnaire (CDQ) [Срок оценки: During screening]
- modified chronic obstructive pulmonary disease diagnostic questionnaire (mCDQ) [Срок оценки: During screening]
- Simple screening questionnaire [Срок оценки: During screening]
- lung function questionnaire (LFQ) [Срок оценки: During screening]
- chronic obstructive pulmonary disease screening questionnaire (COPD-SQ) [Срок оценки: During screening]
- chronic obstructive pulmonary disease population screener questionnaire (COPD-PS) [Срок оценки: During screening]
Критерии участия
Критерии включения
- According to the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021), a multi-stage cluster random sampling method was used to select individuals from representative administrative villages with a history of chronic cough or sputum production, breathing difficulties, recurrent lower respiratory tract infections, and/or exposure to potential risk factors for chronic obstructive pulmonary disease.
- The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.
Критерии исключения
- Patients who are delirious, have impaired consciousness, dementia, various psychiatric disorders, etc., and cannot be accurately informed of their basic physical condition.
- Patients who, in the opinion of the investigator, are not suitable for participation in this study.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Другое
Центры проведения
Китай · 1 центр
- The First Affiliated Hospital of Henan University of Chinese Medicine — Чжэнчжоу
Идентификаторы
NCT: NCT06350305 · Screening for high-risk COPD